Medicare Enrolled
Dr. Ronald Goldberg, M.D.
Interventional Cardiology · La Mesa, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goldberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goldberg
Dr. Ronald Goldberg is an interventional cardiology specialist in La Mesa, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goldberg performed 5,931 Medicare services across 3,288 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goldberg received a total of $141,479 from 58 pharmaceutical and/or device companies across 1053 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goldberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in CA
$141,479 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,931
Medicare services
Top 19% in CA for interventional cardiology
3,288
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~297 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,760 | $68 | $106 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
712 | $44 | $75 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
448 | $161 | $350 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
358 | $76 | $154 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
352 | $53 | $165 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
347 | $64 | $132 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
200 | $158 | $400 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
178 | $393 | $571 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
162 | $21 | $50 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
158 | $11 | $43 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
129 | $103 | $229 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
121 | $70 | $105 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
112 | $23 | $55 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
111 | $44 | $200 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
104 | $7 | $65 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
101 | $40 | $150 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
93 | $20 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $114 | $200 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
63 | $38 | $75 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
63 | $34 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
48 | $95 | $150 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
41 | $18 | $40 |
| Cardiac catheterization | 35 | $178 | $505 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
27 | $763 | $1,500 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
26 | $16 | $119 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $114 | $200 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
24 | $447 | $1,214 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
17 | $18 | $100 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
14 | $89 | $415 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
13 | $4,064 | $7,500 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
13 | $11 | $204 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
11 | $19 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.5% high complexity
32.1% medium
56.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$141,479
Total received (2018-2024)
Avg $20,211/year across 7 years
Top 7% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,053
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$123,167 (87.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,263 (12.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,049 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,310
2023
$11,019
2022
$31,242
2021
$18,923
2020
$5,895
2019
$35,616
2018
$25,474
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$11,392
SCPHARMACEUTICALS INC.
$274
Novartis Pharmaceuticals Corporation
$230
Merck Sharp & Dohme LLC
$217
Abbott Laboratories
$184
Bayer Healthcare Pharmaceuticals Inc.
$155
Amgen Inc.
$130
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$122
AstraZeneca Pharmaceuticals LP
$114
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
PFIZER INC.
$92
Boston Scientific Corporation
$65
E.R. Squibb & Sons, L.L.C.
$57
Lexicon Pharmaceuticals, Inc.
$47
ABIOMED
$42
SANOFI-AVENTIS U.S. LLC
$24
BIOTRONIK INC.
$21
Edwards Lifesciences Corporation
$17
Esperion Therapeutics, Inc.
$15
Actelion Pharmaceuticals US, Inc.
$12
Top 3 companies account for 89.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$120,929
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,724
Abbott Laboratories
$1,698
Medtronic Vascular, Inc.
$1,531
Novartis Pharmaceuticals Corporation
$1,429
AstraZeneca Pharmaceuticals LP
$1,421
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,141
Amgen Inc.
$1,134
PFIZER INC.
$921
ARALEZ PHARMACEUTICALS US INC.
$899
SANOFI-AVENTIS U.S. LLC
$760
ABIOMED
$519
Merck Sharp & Dohme LLC
$511
E.R. Squibb & Sons, L.L.C.
$488
Kowa Pharmaceuticals America, Inc.
$443
Amarin Pharma Inc.
$424
Boston Scientific Corporation
$330
SCPHARMACEUTICALS INC.
$325
Gilead Sciences, Inc.
$299
Medtronic, Inc.
$290
Chiesi USA, Inc.
$256
Impulse Dynamics (USA) Inc.
$241
BIOTRONIK INC.
$234
Philips Electronics North America Corporation
$195
Penumbra, Inc.
$188
Bayer Healthcare Pharmaceuticals Inc.
$155
COMSORT, Inc
$150
Esperion Therapeutics, Inc.
$141
CVRx, Inc.
$141
BOSTON SCIENTIFIC CORPORATION
$140
Actelion Pharmaceuticals US, Inc.
$135
Otsuka America Pharmaceutical, Inc.
$124
Regeneron Healthcare Solutions, Inc.
$122
Daiichi Sankyo Inc.
$122
Novo Nordisk Inc
$115
Lexicon Pharmaceuticals, Inc.
$91
Getinge USA Sales, LLC
$89
Cardinal Health 200, LLC
$82
Alnylam Pharmaceuticals Inc.
$81
ARBOR PHARMACEUTICALS, INC.
$67
Shockwave Medical, Inc
$59
PORTOLA PHARMACEUTICALS, INC.
$35
Merck Sharp & Dohme Corporation
$32
Itamar Medical Inc
$26
HeartFlow, Inc.
$25
Bayer HealthCare Pharmaceuticals Inc.
$21
Kiniksa Pharmaceuticals, Ltd.
$21
Cardiovascular Systems Inc.
$20
Allergan Inc.
$19
Baxter Healthcare
$18
Edwards Lifesciences Corporation
$17
CHIESI USA, INC.
$17
Medtronic USA, Inc.
$17
CathWorks, Inc.
$15
LivaNova USA, Inc.
$15
Arbor Pharmaceuticals, Inc.
$14
Lilly USA, LLC
$13
Phadia US Inc.
$11
Top 3 companies account for 88.6% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · ANDEXXA · AQUAMANTYS · AVEIR · Acticor 7 VR-T DX · Adempas · Amplia MRI · Arcalyst · Assurity Pacemaker · Azure · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor 2 · CAMZYOS · CARDIOMEMS · CLEVIPREX · CONFIRM RX · CardioMEMS HF System · Cardiohelp · Confirm Rx · Corlanor · Crome · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FFRangio · FUROSCIX · Hillrom - Cardiac Ambulatory Monitor · IBRANCE · ICDs · IGT D Coronary · IGT_D Coronary · INJECTAFER · INVOKANA · ImmunoCAP · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LOKELMA · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NAVITOR · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Optis Coronary Imaging System · Orchestra Plus Programmer · Ozempic · PCI Optimization · PK Papyrus · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · QUADRA ASSURA · Quadra Assura CRT Defibrillator · RESONATE · Repatha · Resolute · Reveal LINQ · Rivacor · Rybelsus · SAMSCA · Solia · Tryton Side Branch Stent · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · Welchol · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for interventional cardiology in CA.
Geographic Context
Interventional cardiologists within 10 mi
30
Per 100K population
0.9
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Goldberg is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with speaking/promotional industry engagement in the top 7% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Goldberg experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Goldberg performed 1,760 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldberg receive payments from pharmaceutical companies?
Yes. Dr. Goldberg received a total of $141,479 from 58 companies across 1,053 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldberg's costs compare to other interventional cardiologists in La Mesa?
Dr. Goldberg's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in La Mesa
Browse interventional cardiologists in La Mesa ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology